Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Haemonetics (HAE) over the last 17 years, with Q4 2025 value amounting to $27.4 million.

  • Haemonetics' Depreciation & Amortization (CF) fell 565.03% to $27.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $112.6 million, marking a year-over-year decrease of 209.62%. This contributed to the annual value of $115.6 million for FY2025, which is 1889.73% up from last year.
  • According to the latest figures from Q4 2025, Haemonetics' Depreciation & Amortization (CF) is $27.4 million, which was down 565.03% from $28.3 million recorded in Q3 2025.
  • In the past 5 years, Haemonetics' Depreciation & Amortization (CF) ranged from a high of $29.2 million in Q3 2024 and a low of $21.9 million during Q2 2021
  • Over the past 5 years, Haemonetics' median Depreciation & Amortization (CF) value was $24.6 million (recorded in 2022), while the average stood at $25.5 million.
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first plummeted by 2383.1% in 2021, then soared by 2695.87% in 2024.
  • Quarter analysis of 5 years shows Haemonetics' Depreciation & Amortization (CF) stood at $23.5 million in 2021, then grew by 0.15% to $23.6 million in 2022, then dropped by 0.17% to $23.5 million in 2023, then rose by 23.35% to $29.0 million in 2024, then decreased by 5.65% to $27.4 million in 2025.
  • Its last three reported values are $27.4 million in Q4 2025, $28.3 million for Q3 2025, and $28.8 million during Q2 2025.